Alphina Therapeutics

Redefining precision oncology for ADCs with a novel payload

Westport, United States · Founded 2020 · $40.2M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$40.2M
Last Round
$154K Venture RoundMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Alphina Therapeutics is working to fulfill the promise of precision oncology, aiming for higher response rates for more patients. Its approach uses antibody-drug conjugate (ADC) technology to deliver potent NAMPT inhibitor payloads directly to the tumor, designed to kill both dividing and non-dividing tumor cells. The company has also developed a proprietary test that identifies the patients most likely to benefit from NAMPT inhibitors. Alphina completed a $40 million Series A financing in September 2021 led by Canaan Partners.

Summary

Alphina Therapeutics is a Biotech company based in Westport, United States, founded in 2020. It has raised $40.2M in total across 2 rounds, most recently a $154K Venture Round in Mar 2026. Investors include Canaan Partners, Osage University Partners and Connecticut Innovations.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMar 2026
$154K

Sign up to see all 2 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alphina Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alphina-therapeutics"><img src="https://indexed.vc/api/badge/company/alphina-therapeutics" alt="Alphina Therapeutics on Indexed.vc" width="260" height="76" /></a>